Freedom (FRHC) had the highest return between 2013 and 2022 by a large-cap US stock, returning 277,138.1%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Freedom (FRHC) | 2013-2022 | 277,138.1% |
Celsius (CELH) | 2013-2022 | 37,070.42% |
Tesla (TSLA) | 2013-2022 | 5,179.22% |
NVIDIA (NVDA) | 2013-2022 | 4,940.14% |
Texas Pacific Land Trust (TPL) | 2013-2022 | 4,717.84% |
DexCom (DXCM) | 2013-2022 | 3,161.05% |
Genmab A-S (GMAB) | 2013-2022 | 2,927.14% |
Advanced Micro Devices (AMD) | 2013-2022 | 2,440% |
Ubiquiti Networks (UI) | 2013-2022 | 2,183.25% |
Broadcom (AVGO) | 2013-2022 | 2,133.65% |
Netflix (NFLX) | 2013-2022 | 2,068.01% |
argenx NV ADR (ARGX) | 2013-2022 | 2,016.37% |
Axon Enterprise (AXON) | 2013-2022 | 1,723.41% |
Paycom Soft (PAYC) | 2013-2022 | 1,633.57% |
Monolithic Power Systems (MPWR) | 2013-2022 | 1,591.73% |
MSCI (MSCI) | 2013-2022 | 1,509.08% |
Trade Desk (TTD) | 2013-2022 | 1,459.3% |
Neurocrine Biosciences (NBIX) | 2013-2022 | 1,455.21% |
Kinsale Capital (KNSL) | 2013-2022 | 1,391.65% |
Ensign (ENSG) | 2013-2022 | 1,317.33% |
Fair Isaac (FICO) | 2013-2022 | 1,298.62% |
Insulet (PODD) | 2013-2022 | 1,257.26% |
Lam Research (LRCX) | 2013-2022 | 1,194.45% |
ServiceNow (NOW) | 2013-2022 | 1,162.67% |
Alnylam Pharmaceuticals (ALNY) | 2013-2022 | 1,154.09% |
Large-cap stocks are treated as having a market cap of $10B+.
